返回 Agenda
Sharing the Burden
Session Chair(s)
Deborah Howe
Director, Global Patient Recruitment and Engagement
Alexion, AstraZeneca Rare Disease, United States
Many in industry are interested in identifying new and innovative technologies to engage with patients throughout and after a clinical trial. The industry is enamored with multimedia eConsent platforms, but do they really help speed clinical trials to completion and reduce regulatory burden? When patients receive patient diaries, digital data capture tools, or even digital patient stipends does the learning curve and maintenance of use really benefit the patient? When sites have to log into multiple platforms to obtain study related information, it might require a new password for each platform. A more connected world enabled by digital technology can potentially help open up conversations in the area of clinical research, but it can also create more burden for investigator sites and patients when it is not streamlined or integrated. This session will explore how these innovations are being implemented without adding burden to the sites and patient users. Speakers will discuss how they are innovative but also reducing the added burden onto the site or patient.
Learning Objective : Recognize how to anticipate site and patient burden due to the increased trend of introducing new technology processes; Describe ways to address site and patient burden.
Speaker(s)
How Appropriate Use of Technology Can Share and Reduce the Burden of Modern Clinical Trials
Paul O'Donohoe, MS, MSC
Medidata Solutions, United States
Senior Director, eCOA Product and Science
Patient Perspective
Deborah Collyar
Patient Advocates In Research (PAIR), United States
President